Bevacizumab

Various toxicities: 4 case reports

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      Identifying patient details (age and sex) have been obtained through direct communication with the author.

    Reference

    1. Katic K, et al. First-line treatment of ovarian cancer FIGO stages IIIB-IV: Focus on therapy with bevacizumab - Our experience. Libri Oncologici 47: 64-70, No. 2, Jan 2019. Available from: URL: http://doi.org/10.20471/LO.2019.47.02-03.12

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Bevacizumab. Reactions Weekly 1810, 49 (2020). https://doi.org/10.1007/s40278-020-80069-2

    Download citation